InnoGI Technologies, formerly known as The TIM Company, expands its legacy of expertise within in vitro gastrointestinal models, combining years of experience in oral drug testing. InnoGI Technologies, headquartered in Delft, The Netherlands, has successfully evaluated over 250 active pharmaceutical ingredients found in commercial drug products from both large and small pharmaceutical companies.
As per its name, InnoGI Technologies is driven by the goal of developing innovative technologies and solutions related to realistic GI tract simulations and oral drug delivery for Pharma and Food. InnoGI Technologies has helped guide clients worldwide with decision-making in different stages of oral drug development, i.e., led to decreased formulation iterations, effectively de-risked clinical trials, and shortened time-to-market. This is also evidenced throughout its 250+ scientific publications.